Skip to main content

Table 1 The detailed baseline characteristics information

From: Impact of tourniquet during total knee arthroplasty when tranexamic acid was used: a meta-analysis of randomized controlled trials

The detailed baseline characteristics information

Author/year

Patients

Knees

Mean age (years)

Female gender (%)

BMI

Diagnosis

Tourniquet use with TXA/No tourniquet use with TXA

Alexandersson 2018

38/43

38/43

68/69.7

52.6/48.8

28.6/27.9

38OA/43OA

Concina 2019

50/50

50/50

NA

NA

NA

NA

Ejaz 2014

33/31

33/31

68/68

45.5/45.2

25/25

33OA/31OA

Huang 2017

50/50

50/50

66.2/65.1

64/68

25.1/24.4

50OA/50OA

Ma 2017

31/32

31/32

66.8/67.2

61.3/65.6

24.38/24.02

31OA/32OA

Palanne 20201

101/99

101/99

64/63

72.3/58.6

30.7/30.8

101OA/99OA

Palanne 20202

99/96

99/96

63/65

62.6/61.5

30.5/29

99A/96OA

Wang 2017

30

30/30

65.9/65.9

86.7/86.7

26.6/26.6

30OA/30OA

Wang 2019

30/30

30/30

62.8/64.1

90/73.3

23.48/23.68

30OA/30OA

Xie 2017

45/45

45/45

66.2/66.1

85/75

26.1/25.9

NA

Xue 2018

30/30

30/30

68.2/69.1

60/53.3

NA

30OA/30OA

Yu 2017

40/40

40/40

60.65/62.6

NA

NA

40OA/40OA

Zak 2021

161/166

161/166

66.5/67.6

57/66

30.55/30.63

161OA/166OA

Zeng 2021

50/50

50/50

68.44/68

84/86

25.34/26.13

50OA/50OA

Zhou 2017

72/68

72/68

66.8/69.1

81.9/89.7

26.1/25.7

50OA/52OA; 22RA/16RA

  1. The detailed baseline characteristics information, including the number of TKAs, age, gender, BMI, and two groups' diagnosis
  2. OA, osteoarthritis; RA, rheumatoid arthritis; BMI, body mass index; TXA, tranexamic acid